Search - tctmd.com

Displaying 1 - 10 of 10

Sort: Relevancy | Date

FDA: Class I Recall for Cook Medical’s CrossCath Support Catheters

News Daily News

FDA: Class I Recall for Cook Medical’s CrossCath Support Catheters

December 17, 2019

Rivaroxaban Falls Flat in Antiphospholipid Antibody Syndrome

News Daily News

Rivaroxaban Falls Flat in Antiphospholipid Antibody Syndrome

October 15, 2019

FDA Gives Rivaroxaban Another VTE-Related Indication

News Daily News

FDA Gives Rivaroxaban Another VTE-Related Indication

October 14, 2019

Getting Optimal Arterial and Venous Access for Large-Bore Catheter Procedures

Presentation TCT 2019

Getting Optimal Arterial and Venous Access for Large-Bore Catheter Procedures

Presenter: Michael Rinaldi

September 27, 2019

Case #3: A Large Bore Venous Case With Complications

Presentation TCT 2019

Case #3: A Large Bore Venous Case With Complications

Presenter: David Daniels

September 26, 2019

Arterial and Venous Graft Disease: The Science and Art of Graft Interventions

Presentation TCT 2019

Arterial and Venous Graft Disease: The Science and Art of Graft Interventions

Presenter: Gregory Barsness

September 25, 2019

Young MI Patients’ Ischemic Risk Extends at Least Two Decades

News Conference News ESC 2019

Young MI Patients’ Ischemic Risk Extends at Least Two Decades

September 06, 2019

Bleeding, Myocardial Injury Are Key Drivers of Deaths After Noncardiac Surgery

News Daily News

Bleeding, Myocardial Injury Are Key Drivers of Deaths After Noncardiac Surgery

Michael O'Riordan

July 29, 2019

EXCEL Insights: CABG Outcomes for Left Main CAD Have Improved Substantially

News Daily News

EXCEL Insights: CABG Outcomes for Left Main CAD Have Improved Substantially

Michael O'Riordan

April 22, 2019

Femoral Operators Get Bad Rap in Observational Studies, HEAT-PPCI Suggests

News Daily News

Femoral Operators Get Bad Rap in Observational Studies, HEAT-PPCI Suggests

Michael O'Riordan

January 21, 2019

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.